ArticleThe Journal of pharmacology and experimental therapeutics2010

Regional differential effects of the novel histamine H3 receptor antagonist 6-[(3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-N-methyl-3-pyridinecarboxamide hydrochloride (GSK189254) on histamine release in the central nervous system of freely moving rats.

Patrizia Giannoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.